Skip to contentTANG CAPITAL PARTNERS LP — LA JOLLA PHARMACEUTICAL CO insider: 201 transactions · InsiderLensTANG CAPITAL PARTNERS LP
- 10% owner at INTRABIOTICS PHARMACEUTICALS INC /DE · on record since Mar 31, 2006
- 10% owner at Rain Enhancement Technologies Holdco, Inc. · on record since Jun 1, 2023
- 10% owner at TAPESTRY PHARMACEUTICALS, INC · on record since May 25, 2006
- 10% owner at THRESHOLD PHARMACEUTICALS INC · on record since Aug 21, 2006
- 10% owner at ARADIGM CORP · on record since Jan 29, 2007
- 10% owner at Singular Genomics Systems, Inc. · on record since Sep 18, 2024
- 10% owner at AP PHARMA INC /DE/ · on record since Jun 18, 2007
- 10% owner at DEPOMED INC · on record since Jan 28, 2008
- 10% owner at Northstar Neuroscience, Inc. · on record since Apr 28, 2008
- 10% owner at NEOSE TECHNOLOGIES INC · on record since Sep 30, 2008
- 10% owner at Vanda Pharmaceuticals Inc. · on record since Sep 29, 2008
- 10% owner at PENWEST PHARMACEUTICALS CO · on record since Feb 27, 2009
- Director at AP PHARMA INC /DE/ · on record since May 26, 2010
- 10% owner at Mirati Therapeutics, Inc. · on record since Sep 23, 2013
- 10% owner at LA JOLLA PHARMACEUTICAL CO · on record since Sep 26, 2014
- 10% owner at ACLARA BIOSCIENCES INC · on record since Dec 14, 2004
- 10% owner at XCYTE THERAPIES INC · on record since Feb 27, 2017
- 10% owner at Odonate Therapeutics, Inc. · on record since Dec 8, 2017
- 10% owner at Aptevo Therapeutics Inc. · on record since Nov 6, 2020
- Exit Filing at Aptevo Therapeutics Inc. · on record since Nov 26, 2021
- 10% owner at Jounce Therapeutics, Inc. · on record since Mar 14, 2023
- 10% owner at TCR2 THERAPEUTICS INC. · on record since May 30, 2023
Insider trading activity of TANG CAPITAL PARTNERS LP
- Transactions on record
- 201
- since Dec 14, 2004
- Open-market buys
- 153
- $181.2M
- Open-market sells
- 29
- $21M
- Companies traded
- 16
- last filing Feb 14, 2024
Figures computed from official regulatory filings — methodology.
Companies where TANG CAPITAL PARTNERS LP has traded
- TCR2 THERAPEUTICS INC.9 tx · $797.7K · Feb 14, 2024
- Rain Enhancement Technologies Holdco, Inc.4 tx · $209.4K · Feb 2, 2024
- LA JOLLA PHARMACEUTICAL CO54 tx · $48.7M · Dec 1, 2021
- Aptevo Therapeutics Inc.33 tx · $41.7M · Nov 26, 2021
- Odonate Therapeutics, Inc.34 tx · $54M · Sep 30, 2020
- AP PHARMA INC /DE/16 tx · $46.9M · Apr 2, 2018
- XCYTE THERAPIES INC1 tx · $582.4K · Feb 27, 2017
- Mirati Therapeutics, Inc.1 tx · $1M · Oct 28, 2013
- INTRABIOTICS PHARMACEUTICALS INC /DE12 tx · $7.5M · Jan 24, 2011
Track record of TANG CAPITAL PARTNERS LP
Statistical track record
Free- Open-market buys
- 154
- Last buy
- May 25, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of TANG CAPITAL PARTNERS LP
Co-insiders of TANG CAPITAL PARTNERS LP
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Davis Aaron I.ARADIGM CORP +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Feb 14, 2024 | Other | -4,394,800 | — | — | SEC |
| Feb 2, 2024 | Other | -3,850,513 | — | — | SEC |
| Dec 18, 2023 | Sell | -24,406 | 1.21 USD | $29.5K | SEC |
| Dec 18, 2023 | Sell | -109,435 | 1.20 USD | $131.3K | SEC |
| Dec 18, 2023 | Sell | -40,132 | 1.21 USD | $48.6K | SEC |
| May 30, 2023 | Buy | 50,000 | 1.72 USD | $86K | SEC |
| May 10, 2023 | Buy | 6,774 | 1.95 USD | $13.2K | SEC |
| May 10, 2023 | Buy | 57,073 | 1.95 USD | $111.3K | SEC |
| May 10, 2023 | Buy | 20,141 | 1.95 USD | $39.3K | SEC |
| May 5, 2023 | Buy | 104,241 | 1.86 USD | $193.9K | SEC |
| May 5, 2023 | Buy | 71,064 | 1.94 USD | $137.9K | SEC |
| May 5, 2023 | Buy | 95,759 | 1.90 USD | $181.9K | SEC |
| May 5, 2023 | Buy | 18,513 | 1.85 USD | $34.2K | SEC |
| Dec 1, 2021 | Sell | -136,255 | 3.76 USD | $512.3K | SEC |
| Dec 1, 2021 | Sell | -6,597 | 3.95 USD | $26.1K | SEC |
| Dec 1, 2021 | Sell | -41,290 | 3.66 USD | $151.1K | SEC |
| Dec 1, 2021 | Sell | -63,745 | 3.95 USD | $251.8K | SEC |
| Dec 1, 2021 | Sell | -193,403 | 4.10 USD | $793K | SEC |
| Nov 26, 2021 | Sell | -200,000 | 10.07 USD | $2M | SEC |
| Nov 26, 2021 | Sell | -50,889 | 10.43 USD | $530.8K | SEC |
| Nov 26, 2021 | Sell | -160,000 | 9.60 USD | $1.5M | SEC |
| Nov 26, 2021 | Sell | -161,336 | 13.52 USD | $2.2M | SEC |
| Nov 26, 2021 | Sell | -124,509 | 12.45 USD | $1.6M | SEC |
| Nov 26, 2021 | Sell | -75,491 | 11.74 USD | $886.3K | SEC |
| Nov 26, 2021 | Sell | -149,111 | 11.19 USD | $1.7M | SEC |